Point72 Asset Management, L.P. - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 198 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2022$48,707,000
+52.8%
1,524,485
+65.7%
0.21%
+62.2%
Q1 2022$31,876,000
+493.6%
920,200
+401.6%
0.13%
+504.8%
Q4 2021$5,370,000
-93.6%
183,471
-94.5%
0.02%
-94.3%
Q3 2021$84,405,000
-21.3%
3,312,600
+8.2%
0.37%
-22.9%
Q2 2021$107,217,000
+98.5%
3,061,600
+131.0%
0.48%
+90.9%
Q1 2021$54,013,000
+2266.9%
1,325,482
+2416.1%
0.25%
+2190.9%
Q4 2020$2,282,000
-17.2%
52,680
+5.4%
0.01%
-21.4%
Q3 2020$2,757,000
-79.6%
50,000
-76.6%
0.01%
-84.1%
Q2 2020$13,517,000
-7.9%
214,113
-25.5%
0.09%
-26.1%
Q1 2020$14,684,000
-74.2%
287,417
-59.8%
0.12%
-60.1%
Q4 2019$56,810,000
+65.4%
714,681
+1.0%
0.30%
+41.2%
Q3 2019$34,343,000
-34.6%
707,808
-39.1%
0.21%
+0.5%
Q2 2018$52,550,000
+335.2%
1,162,600
+365.0%
0.21%
+320.0%
Q1 2018$12,075,000
-28.0%
250,000
-41.4%
0.05%
-30.6%
Q4 2017$16,775,000
-73.3%
426,300
-78.9%
0.07%
-74.3%
Q3 2017$62,805,000
+228.6%
2,022,700
+189.5%
0.28%
+161.7%
Q2 2017$19,111,000
+26.2%
698,766
+70.0%
0.11%
+27.4%
Q1 2017$15,149,000
+750.6%
411,100
+266.1%
0.08%
+500.0%
Q1 2016$1,781,000112,3000.01%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q2 2021
NameSharesValueWeighting ↓
Grace Capital 177,414$14,103,00011.50%
Fernwood Investment Management, LLC 258,012$20,509,0009.81%
Perceptive Advisors 5,865,726$466,266,0009.26%
ArchPoint Investors 186,756$14,845,0004.54%
STANSBERRY ASSET MANAGEMENT, LLC 115,638$9,192,0003.74%
Camber Capital Management LP 730,000$58,028,0002.95%
Profit Investment Management, LLC 46,873$3,726,0002.50%
Casdin Capital, LLC 300,000$23,847,0002.19%
SECTORAL ASSET MANAGEMENT INC 174,594$13,878,0002.07%
Corriente Advisors, LLC 40,000$3,180,0001.71%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders